Stugeron is a medicine that belongs to a wide class of drugs also known as antihistamines. Like any other antihistamine, Stugeron is known to block histamine receptors (these receptors are found in a lot of body sites, including the brain's vomiting centre). Therefore, Stugeron blocks the histamine receptors found in the patient's vomiting centre, preventing the brain from sending any nerve message that would regularly result in vomiting to the stomach. However, vomiting could be triggered by a lot of stimuli that act at the brain's vomiting centre. This also includes provocative movement (this is the case of Motion sickness in a boat or in a car) and vestibular (inner ear) disorders. This is why Stugeron has be designed not only to treat nausea, but also the vomiting that has been associated with other vestibular disorders (for example Meniere's disease) but also with Motion sickness.
Stugeron is a drug that is able to relieve some other symptoms of the inner ear (vestibular) disorder. These symptoms include tinnitus (also known as ringing in the ear) and vertigo, although it has not been clearly determined how Stugeron works in these cases.
The drug's peak (highest) plasma levels are regularly obtained from 1 to 3 hours after the medicine's intake. Stugeron is known to have a half-life of about 4 hours before it completely disappears from the patient's plasma.
Stugeron is a drug that is known to be completely metabolised. It is thought that 1/3 of the drug's metabolites should be eliminated through urination while the other two thirds through the faeces.
The body's plasma proteic binding of Stugeron is about 91%.
Stugeron is a drug that is commonly prescribed in the treatment and in the control of some inner year (vestibular) symptoms that can be of both central and peripheral origin and of some labyrinth diseases such as dizziness, vertigo, tinnitus, nausea, vomiting, etc. Besides treating some inner year diseases and preventing Motion sickness Stugeron can also be prescribed as an adjunct treatment for patients who are suffering from peripheral arterial disorders.
Patients who are suffering from severe hypersensitivity to Stugeron or to any of its ingredients should not start a treatment with Stugeron. Moreover, patients who are suffering from Parkinson's disease (or who have a family history of this illness) might not be allowed to take Stugeron. In these cases, the patients might be given a lower Stugeron dose. Also, their doctor should carefully monitor the way in which their body responds to the treatment (in order to avoid irreparable damage).
Stugeron is known to lead to symptoms like impaired concentration and drowsiness. These symptoms can be aggravated if the patient is drinking alcoholic beverages or is taking any type of central nervous system (CNS) drugs (especially depressants) during his or her treatment with Stugeron. During their treatment with Stugeron, patients should avoid operating complicated devices and driving of motor vehicles.
The effects that a treatment with Stugeron has on a growing fetus have not been clearly determined. Therefore, if you are pregnant or are planning to become pregnant soon, you must ask for your doctor's opinion before you start taking Stugeron. However, you should ask for your doctor's consent before you start taking Stugeron if you are breasfeeding an infant.
Ask your doctor how and when you should take Stugeron. You must not disobey any of the instructions that your physician has given you.
The average dose of Stugeron in the case of children over 12 and adults is:
Peripheral circulatory diseases: two or three tablets of Stugeron, taken three times per day.
Balance disorder: one tablet of Stugeron three times per day.
The maximum recommended dosage should not exceed 225 mg (9 tablets) daily - if necessary the dosage may be divided over 2 or 3 intakes per day. As the effect of Stugeron tablets on vertigo is dose dependent, the dosage should be increased progressively.
In case of motions sickness:
Adults: should take a 25 mg tablet of Stugeron 2 hours before the beginning of the journey. If necessary, they can take another Stugeron pill every 8 hours during the journey.
Children from 8 to 12 years: they should take half of a Stugeron tablet about three times per day.
Children from 5 to 7 years: should only take 6,25 mg of Stugeron three times per day.
It is known that a Stugeron overdose can have lethal effects especially in children and infants that are taking Stugeron to stimulate parts of their central nervous system. In the case of children, Stugeron overdose symptoms are known to include hallucinations, ataxia, muscle tremor, excitement, dry mouth, dilated pupils, convulsions, hyperpyrexia and flushed face. After 18 hours cardiorespiratory collapse, deepening coma, and sometimes even death can occur. Adult symptoms include convulsions, coma and hypertension.
If you suspect that you are suffering from an overdose with Stugeron you might be in need of immediate medical care.
If you happen to miss one of you Stugeron doses, ask your doctor for further instructions.
Among Stugeron's side effects are:
- Dry mouth;
- Gut disturbances like diarrhea, nausea, constipation, abdominal pain or vomiting;
- Weight gain;
Alert your personal physician if you experience anything bothersome during your treatment with Stugeron.
Ask for your doctor's consent before taking any other drugs during a treatment with Stugeron.
Other Brand Names
In some countries Stugeron may also be known as: